Your browser doesn't support javascript.
loading
Temozolomide promotes immune escape of GBM cells via upregulating PD-L1.
Wang, Silu; Yao, Fuli; Lu, Xianghe; Li, Qun; Su, Zhipeng; Lee, Jong-Ho; Wang, Chengde; Du, Linyong.
Afiliação
  • Wang S; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University Wenzhou 325000, Zhejiang, P. R. China.
  • Yao F; Department of Biochemistry and Molecular Biology, College of Preclinical Medicine, Southwest Medical University Luzhou, P. R. China.
  • Lu X; Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University Wenzhou 325000, Zhejiang, P. R. China.
  • Li Q; Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University Wenzhou 325000, Zhejiang, P. R. China.
  • Su Z; Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University Wenzhou 325000, Zhejiang, P. R. China.
  • Lee JH; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas 77030, USA.
  • Wang C; Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University Wenzhou 325000, Zhejiang, P. R. China.
  • Du L; School of Laboratory Medicine and Life Science, Wenzhou Medical University Wenzhou 325035, Zhejiang, P. R. China.
Am J Cancer Res ; 9(6): 1161-1171, 2019.
Article em En | MEDLINE | ID: mdl-31285949

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2019 Tipo de documento: Article